Jilin Zixin Pharmaceutical Industrial Co. Ltd. | Ownership
Companies that own Jilin Zixin Pharmaceutical Industrial Co. Ltd.
Everbright Xinglong Trust Co. Ltd.
26,991,234
2.11%
26,991,234
4.18%
09/30/2017
China Fortune International Trust Co. Ltd.
10,753,000
0.84%
10,753,000
0.81%
09/30/2017
China Southern Asset Management Co., Ltd.
2,301,676
0.18%
-125,000
0.02%
12/31/2017
The Vanguard Group, Inc.
833,200
0.07%
0
0%
07/31/2018
CCB Principal Asset Management Co., Ltd.
609,095
0.05%
453,495
0.01%
12/31/2016
GF Fund Management Co., Ltd.
485,394
0.04%
-53,744
0.01%
12/31/2017
Harvest Fund Management Co., Ltd.
130,040
0.01%
-42,002
0%
12/31/2017
CITIC-Prudential Fund Management Co., Ltd.
117,802
0.01%
-120,700
0%
12/31/2017
China Asset Management Co., Ltd.
102,900
0.01%
-4,700
0%
12/31/2017
Tian Hong Asset Management Co., Ltd.
69,404
0.01%
-12,600
0%
12/31/2017
About Jilin Zixin Pharmaceutical Industrial Co.
View Profile
| Address |
No. 137 Dongtoudao Street
Changchun Jilin 130041
China
|
|
Employees
|
- |
| Website |
http://www.jilinzixin.com.cn |
| Updated |
07/08/2019 |
| Jilin Zixin Pharmaceutical Industrial Co., Ltd. engages in the research, development, manufacture, and sale of herbal medicines. Its medicine offers treatment for cardiovascular and cerebrovascular diseases, digestive system diseases, and bone fracture. The company was founded on May 25, 1998 and is headquartered in Changchun, China. |
